Cargando…

Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy

While a plethora of studies support a therapeutic benefit of Nrf2 activation and ROS inhibition in diabetic nephropathy (dNP), the Nrf2 activator bardoxolone failed in clinical studies in type 2 diabetic patients due to cardiovascular side effects. Hence, alternative approaches to target Nrf2 are re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahzad, Khurrum, Bock, Fabian, Al-Dabet, Moh’d Mohanad, Gadi, Ihsan, Nazir, Sumra, Wang, Hongjie, Kohli, Shrey, Ranjan, Satish, Mertens, Peter R., Nawroth, Peter P., Isermann, Berend
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056367/ https://www.ncbi.nlm.nih.gov/pubmed/27721446 http://dx.doi.org/10.1038/srep34228

Ejemplares similares

Activated protein C reverses epigenetically sustained p66(Shc) expression in plaque-associated macrophages in diabetes
por: Shahzad, Khurrum, et al.
Publicado: (2018)

Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
por: Shahzad, Khurrum, et al.
Publicado: (2015)

Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease
por: Gupta, Anubhuti, et al.
Publicado: (2022)

Reversal of the renal hyperglycemic memory in diabetic kidney disease by targeting sustained tubular p21 expression
por: Al-Dabet, Moh’d Mohanad, et al.
Publicado: (2022)

Correction: Gupta et al. Neutrophil Extracellular Traps Promote NLRP3 Inflammasome Activation and Glomerular Endothelial Dysfunction in Diabetic Kidney Disease. Nutrients 2022, 14, 2965
por: Gupta, Anubhuti, et al.
Publicado: (2023)

p45 NF-E2 regulates syncytiotrophoblast differentiation by post-translational GCM1 modifications in human intrauterine growth restriction
por: Kohli, Shrey, et al.
Publicado: (2017)

Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C
por: Kohli, Shrey, et al.
Publicado: (2022)

Activated Protein C Ameliorates Tubular Mitochondrial Reactive Oxygen Species and Inflammation in Diabetic Kidney Disease
por: Rana, Rajiv, et al.
Publicado: (2022)

Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via α-ketoglutarate
por: Gupta, Dheerendra, et al.
Publicado: (2023)

Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy
por: Madhusudhan, Thati, et al.
Publicado: (2015)

Procoagulant Extracellular Vesicles Alter Trophoblast Differentiation in Mice by a Thrombo-Inflammatory Mechanism
por: Markmeyer, Paulina, et al.
Publicado: (2021)

Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells
por: Ranjan, Satish, et al.
Publicado: (2017)

Novel Nongenetic Murine Model of Hyperglycemia and Hyperlipidemia-Associated Aggravated Atherosclerosis
por: Gaul, Susanne, et al.
Publicado: (2022)

Vaccine-Induced Thrombotic Thrombocytopenia: Insights from Blood Smear
por: Zimmermann, Silke, et al.
Publicado: (2021)

Evaluation of Plaque Stability of Advanced Atherosclerotic Lesions in Apo E-Deficient Mice after Treatment with the Oral Factor Xa Inhibitor Rivaroxaban
por: Zhou, Qianxing, et al.
Publicado: (2011)

Hypercoagulability Impairs Plaque Stability in Diabetes-Induced Atherosclerosis
por: Ambreen, Saira, et al.
Publicado: (2022)

Elevated Expression of the RAGE Variant-V in SCLC Mitigates the Effect of Chemotherapeutic Drugs
por: Madhavan, Bindhu K., et al.
Publicado: (2021)

ER-Stress and Senescence Coordinately Promote Endothelial Barrier Dysfunction in Diabetes-Induced Atherosclerosis
por: Fatima, Sameen, et al.
Publicado: (2022)

Elevated markers of DNA damage and senescence are associated with the progression of albuminuria and restrictive lung disease in patients with type 2 diabetes
por: Varun, Kumar, et al.
Publicado: (2023)

Lower Plasma Creatinine and Urine Albumin in Individuals at Increased Risk of Type 2 Diabetes with Factor V Leiden Mutation
por: Peter, Andreas, et al.
Publicado: (2014)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Sphingosine Kinases are Involved in Macrophage NLRP3 Inflammasome Transcriptional Induction
por: Syed, Shahzad Nawaz, et al.
Publicado: (2020)

Gene expression profile of CD14(+) blood monocytes following lifestyle-induced weight loss in individuals with metabolic syndrome
por: Biemann, Ronald, et al.
Publicado: (2020)

RAGE Controls Activation and Anti-Inflammatory Signalling of Protein C
por: Braach, Natascha, et al.
Publicado: (2014)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

A two-and-a-half-year-old breastfed toddler presenting with anemia: a case report
por: Bock, Fabian, et al.
Publicado: (2014)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

The role of the NLRP3 inflammasome in gout
por: Kingsbury, Sarah R, et al.
Publicado: (2011)

The Role of the NLRP3 Inflammasome in Fibrosis
por: Artlett, Carol M
Publicado: (2012)

NLRP3 Inflammasome and MS/EAE
por: Inoue, Makoto, et al.
Publicado: (2013)

NLRP3 Inflammasome and Pathobiology in AMD
por: Celkova, Lucia, et al.
Publicado: (2015)

Role of the NLRP3 inflammasome in cancer
por: Moossavi, Maryam, et al.
Publicado: (2018)

Spotlight on the NLRP3 inflammasome pathway
por: Groslambert, Marine, et al.
Publicado: (2018)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

Role of NLRP3 Inflammasomes in Atherosclerosis
por: Karasawa, Tadayoshi, et al.
Publicado: (2017)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6n9m6q3g4tlffpdn1m27235ik8